Weiner L S, Howell J T, Langford M P, Stanton G J, Baron S, Goldblum R M, Lord R A, Goldman A S
J Infect Dis. 1979 Dec;140(6):858-63. doi: 10.1093/infdis/140.6.858.
The effects of specific antibodies in chronic echovirus type 5 (echo 5) encephalitis were investigated in a patient with x-linked hypogammaglobulinemia. Virus was detected in cerebrospinal fluid (CSF) and blood despite treatment with commercial human gammaglobulin that contained low titers of antibodies to echo 5 (0.6 x 10(4) units per injection). Virus disappeared from blood and CSF when plasma containing high concentrations of antibodies (total dose, 1--4 x 10(4) units/kg) was administered intravenously. Maximal inhibition of virus was achieved in culture and in the patient's CSF when the titer of antibody to echo 5 in CSF was greater than or equal to 16 units/ml. Although the patient died, hyperimmune plasma improved the neurologic status and eliminated detectable virus from the blood and CSF.
在一名患有X连锁低丙种球蛋白血症的患者中,研究了特异性抗体在慢性埃可病毒5型(埃可5型)脑炎中的作用。尽管使用了含有低滴度埃可5型抗体(每次注射0.6×10⁴单位)的商业人丙种球蛋白进行治疗,但在脑脊液(CSF)和血液中仍检测到病毒。当静脉注射含有高浓度抗体(总剂量,1 - 4×10⁴单位/千克)的血浆时,病毒从血液和脑脊液中消失。当脑脊液中埃可5型抗体滴度大于或等于16单位/毫升时,在培养物和患者脑脊液中实现了对病毒的最大抑制。尽管患者死亡,但超免疫血浆改善了神经状态,并从血液和脑脊液中清除了可检测到的病毒。